Videos
Psychedelics in Psychiatry
Speaking at a webinar back in September 2021, Prof. Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine, presented his research on psilocybin and its potential for positive long term outcomes in both healthy participants and in individuals with psychiatric disorders.
Cannabis Standardization: Product Quality Specification and Certification Programs Are Finally Here
Speaking at a webinar in July 2021, David Vaillencourt, CEO of The GMP Collective and Darwin Millard, The Spock of Cannabis, presented an update on cannabis testing standards for 2021.
The Status of Microbial Testing in the U.S. Cannabis Industry and Future Outlooks
Speaking at a webinar back in April 2021, Morgan Boyle, Lead Microbiologist and Cannabis Science Consultant, presented her talk on the current status of microbial testing requirements.
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability (PHATHOM)
Speaking at a webinar in July 2021, Gül Dölen, Associate Professor of Neuroscience at The Johns Hopkins University, presented her research into the therapeutic effects and the mechanism of action of MDMA.
Challenges of Regulatory Oversight, Quality Testing, and Standardization within a Global Patchwork of Hemp Markets
Speaking at an Analytical Cannabis webinar in January 2022, Kim Ross, PhD, Chief Science Officer at Peak Compliance LLC, presented her talk on hemp regulation, testing and standardization.
Uncovering the Lineage of Extraction and the Future of the Craft
Speaking at a webinar in March 2021, Alisia Ratliff, CEO of Victus Capital Ventures, presented the history of extraction and methodologies as well as what the future holds.
2-Minute Neuroscience: THC
This video, courtesy of the Neuroscientifically Challenged YouTube channel, discusses the effects of THC on the nervous system.
Cannabis in Context: Health, Regulations and Listening to the Science
Speaking at a webinar in February 2021, Chris Tasker, Chief Executive Officer of Global Cannabinoid Solutions presented about current UK cannabis legislation and proposed law improvements within the UK.
The Potential of Psychedelic Medicine to Transform Mental Health Treatment
Speaking at a webinar in March 2021, Cosmo Feilding-Mellen, Co-Founder & Chief Executive of Beckley Psytech, explored the promising medical qualities of psychedelics, such as LSD and psilocybin “magic” mushrooms
Formulating Cannabinoid Particles for Therapeutics
Speaking at a webinar in February 2021, Dr Natalia Sannikova, Research & Development Manager and Tomas Skrinskas, Founder & CEO from Ascension Sciences presented their research of cannabinoid nanoparticles.
